NASDAQ · Biotechnology

VCEL (VCEL) Stock

$45.96 -3.47% NASDAQ: VCEL Healthcare

Valuation

MetricValue
Price$45.96
Market Cap$2.35B
P/E Ratio107.78
P/B Ratio4.96
P/S Ratio6.03
EPS (TTM)$0.32
52-Week High$48.54
52-Week Low$28.95
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE4.79%
ROA3.48%
ROCE3.10%
Gross Margin3.99%
Operating Margin3.99%
Net Margin7.35%
Debt/Equity0.27
Current Ratio5.04

Annual Financials (USD)

Metric20212022202320242025
Revenue$156.0M$164.0M$198.0M$237.0M$276.0M
Operating Profit$-8.0M$-17.0M$-6.0M$5.0M$11.0M
Net Profit$-7.0M$-17.0M$-3.0M$10.0M$17.0M
EPS$-0.16$-0.35$-0.07$0.20$0.32
Op Margin-5.0%-10.4%-3.3%1.9%4.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$244.0M$273.0M$354.0M$433.0M$488.0M
Total Liabilities$73.0M$81.0M$128.0M$141.0M$133.0M
Cash$68.0M$51.0M$69.0M$75.0M$100.0M
Borrowings$50.0M$48.0M$88.0M$99.0M$98.0M

Latest News

VCEL: What does Argus have to say about VCEL? Argus Research · Jul 22, 2026 Truist Securities Adjusts Price Target on Vericel to $54 From $42, Maintains Buy Rating MT Newswires · Jul 16, 2026 Vericel to Report Second Quarter 2026 Financial Results on July 30, 2026 GlobeNewswire · Jul 16, 2026 Vericel Stock Is Up 10%. Here's What This $402,000 Insider Sale Really Suggests Motley Fool · Jun 27, 2026 Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026 GlobeNewswire · Jun 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$29.0M$18.0M$35.0M$58.0M$52.0M
Investing Cash Flow$-11.0M$-44.0M$-31.0M$-143.0M$-71.0M
Financing Cash Flow$-2.0M$-3.0M$-2.0M$-5.0M$-7.0M
Net Cash Flow$35.0M$-17.0M$36.0M$-2.0M$15.0M
Free Cash Flow$21.0M$10.0M$8.0M$-6.0M$25.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA79.97
FCF Yield3.28%
Quick Ratio4.79
Interest Coverage5.50
Return 1Y17.32%
Return 3Y15.08%
Return 5Y-16.30%

Ownership

Insiders Held1.19%
Institutions Held113.74%
Institutions Float Held115.11%
Institutional HolderSharesReport Date
Blackrock Inc.7,765,3442026-03-31
State Street Corporation3,152,1302026-03-31
Congress Asset Management Co2,916,2952026-06-30
Soleus Capital Management, L.P.2,549,0792026-03-31
Conestoga Capital Advisors, LLC2,463,3122026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About VCEL

VCEL stock trades at $45.96 with a market capitalization of $2.35B. The stock is valued at a price-to-earnings (P/E) ratio of 107.78, price-to-book of 4.96, price-to-sales of 6.03. Over the past 52 weeks the stock has ranged between $28.95 and $48.54, and currently trades 5.3% below its 52-week high.

On profitability, VCEL generates a return on equity (ROE) of 4.79%, return on capital employed of 3.10%, an operating margin of 3.99%, a net profit margin of 7.35%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides